Zura Bio Statistics

Total Valuation

Zura Bio has a market cap or net worth of $243.19 million. The enterprise value is $104.17 million.

Market Cap	243.19M
Enterprise Value	104.17M

Important Dates

The last earnings date was Thursday, November 13, 2025, before market open.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Zura Bio has 65.02 million shares outstanding. The number of shares has increased by 45.40% in one year.

Current Share Class	65.02M
Shares Outstanding	65.02M
Shares Change (YoY)	+45.40%
Shares Change (QoQ)	+0.29%
Owned by Insiders (%)	6.91%
Owned by Institutions (%)	43.25%
Float	33.46M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.25
P/TBV Ratio	2.25
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.58

Current Ratio	5.58
Quick Ratio	5.45
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -45.01% and return on invested capital (ROIC) is -31.36%.

Return on Equity (ROE)	-45.01%
Return on Assets (ROA)	-27.24%
Return on Invested Capital (ROIC)	-31.36%
Return on Capital Employed (ROCE)	-61.27%
Revenue Per Employee	n/a
Profits Per Employee	-$2.08M
Employee Count	30
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +36.50% in the last 52 weeks. The beta is 0.24, so Zura Bio's price volatility has been lower than the market average.

Beta (5Y)	0.24
52-Week Price Change	+36.50%
50-Day Moving Average	3.78
200-Day Moving Average	2.02
Relative Strength Index (RSI)	49.92
Average Volume (20 Days)	405,443

Short Selling Information

The latest short interest is 2.57 million, so 3.95% of the outstanding shares have been sold short.

Short Interest	2.57M
Short Previous Month	2.72M
Short % of Shares Out	3.95%
Short % of Float	7.68%
Short Ratio (days to cover)	4.18

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-72.57M
Pretax Income	-65.10M
Net Income	-62.52M
EBITDA	-72.53M
EBIT	-72.57M
Earnings Per Share (EPS)	-$0.67

Full Income Statement

Balance Sheet

The company has $139.02 million in cash and n/a in debt, giving a net cash position of $139.02 million or $2.14 per share.

Cash & Cash Equivalents	139.02M
Total Debt	n/a
Net Cash	139.02M
Net Cash Per Share	$2.14
Equity (Book Value)	118.44M
Book Value Per Share	1.66
Working Capital	116.80M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$53.36 million and capital expenditures -$141,000, giving a free cash flow of -$53.50 million.

Operating Cash Flow	-53.36M
Capital Expenditures	-141,000
Free Cash Flow	-53.50M
FCF Per Share	-$0.82

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Zura Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-45.40%
Shareholder Yield	-45.40%
Earnings Yield	-25.71%
FCF Yield	-22.00%

Analyst Forecast

The average price target for Zura Bio is $11.38, which is 204.28% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$11.38
Price Target Difference	204.28%
Analyst Consensus	Strong Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1